Profil
Dr. Steven D.
Reich, MD, is a Chief Medical Officer at Artelo Biosciences, Inc. and a Vice President-Clinical Development at Actuate Therapeutics, Inc. Dr. Reich was previously employed as a Chief Executive & Medical Officer by Anaborex, Inc. He received his graduate degree from the University of Medicine & Dentistry of New Jersey and a doctorate degree from the University of Medicine & Dentistry of New Jersey.
Aktive Positionen von Steven D. Reich
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2018 |
| ACTUATE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Steven D. Reich
| Unternehmen | Position | Ende |
|---|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | Präsident | 31.12.2012 |
Ausbildung von Steven D. Reich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | Health Services |
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
















